Variant position: 1115 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1343 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human PEPSYGPARPRQQSLSKEGS IGGSGGSGGGGGGGLKPSITK
Mouse PEPSYGPARPRQQSLSKEGS IGGSGGSGGGGGGGLKPSITK
Rat PEPSYGPARPRQQSLSKEGS IGGSGGSGGGGGGGLKPSITK
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 1343 Ras/Rap GTPase-activating protein SynGAP
1114 – 1114 Phosphoserine
1118 – 1118 Phosphoserine
1121 – 1121 Phosphoserine
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation.
Hamdan F.F.; Gauthier J.; Spiegelman D.; Noreau A.; Yang Y.; Pellerin S.; Dobrzeniecka S.; Cote M.; Perreault-Linck E.; Carmant L.; D'Anjou G.; Fombonne E.; Addington A.M.; Rapoport J.L.; Delisi L.E.; Krebs M.O.; Mouaffak F.; Joober R.; Mottron L.; Drapeau P.; Marineau C.; Lafreniere R.G.; Lacaille J.C.; Rouleau G.A.; Michaud J.L.;
N. Engl. J. Med. 360:599-605(2009)
Cited for: INVOLVEMENT IN MRD5; VARIANTS GLU-201; GLN-749; ASN-790; THR-1115; LEU-1283 AND MET-1310;
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism.
Hamdan F.F.; Daoud H.; Piton A.; Gauthier J.; Dobrzeniecka S.; Krebs M.O.; Joober R.; Lacaille J.C.; Nadeau A.; Milunsky J.M.; Wang Z.; Carmant L.; Mottron L.; Beauchamp M.H.; Rouleau G.A.; Michaud J.L.;
Biol. Psychiatry 69:898-901(2011)
Cited for: INVOLVEMENT IN MRD5; VARIANTS ARG-991 AND THR-1115;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.